% Expired Patents = 11.1

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 54

Loading Chart...

3 inventors (with patents filed for the assignee):

Jonathan Edelson (6 out of 11 patents)

Timothy Kotyla (6 out of 6 patents)

Boke Zhang (1 out of 5 patents)

4. Klaus Theobald (1 patent)

9 patents: Sort by Forward Citations

1. 10905637 - Peptide nanoparticles and uses therefor (2021-02-02),

2. 10758485 - Amphiphilic entity nanoparticles (2020-09-01),

3. 10485855 - Demonstrable efficacy across or within patient populations (2019-11-26),

4. 10285941 - Amphiphilic entity nanoparticles (2019-05-14),

5. 10016451 - Nucleic acid nanoparticles and uses therefor (2018-07-10),

6. 9724299 - Amphiphilic entity nanoparticles (2017-08-08),

7. 9649266 - Methods to treat, prevent, and improve skin conditions (2017-05-16),

8. 9486409 - Peptide nanoparticles and uses therefor (2016-11-08),

9. 8658391 - Assessment of the effects of topical administration of chemodenervating pharmaceuticals (2014-02-25),

Company Overview

Anterios, Inc. is a biopharmaceutical company focused on developing novel aesthetic treatments utilizing their proprietary transdermal delivery technology. Their lead product, NANOG, is a botulinum toxin type A product that penetrates the skin more effectively, providing better results with less discomfort for patients. Anterios is dedicated to advancing the field of dermatology and improving patient outcomes through innovative solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#765 in New York, NY

#1,905 in New York

#32,605 in US

New York, NY, United States of America

Anterios, Inc.

Forward Citations = 54

3 inventors:

Jonathan Edelson (6 out of 11 patents)

Timothy Kotyla (6 out of 6 patents)

Boke Zhang (1 out of 5 patents)

4. Klaus Theobald (1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Anterios, Inc.. Retrieved from https://idiyas.com/company/anterios

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]